Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL286622 | 0.81 | CA2 (0.47) | CA1CA2CA7CA13 | |
| Trifluoromethanesulfonamide SCHEMBL25383981 | 0.79 | CA1 (0.55) | LMNACA1CA2CA7CA13 | |
| Trifluoromethanesulfonic Acid SCHEMBL1462277 | 0.72 | LMNA (0.53) | LMNACA1CA2CA7CA13 | |
| Acrylic Acid SCHEMBL7769059 | 0.71 | LMNA (0.59) | LMNACA1CA2CA7ALOX15 | |
| Dioxane SCHEMBL12501651 | 0.69 | CA1 (0.36) | CA1CA2CA7CA13 | |
| Dioxane SCHEMBL15201962 | 0.69 | CA1 (0.36) | CA1CA2CA7CA13 | |
| Acrylic Acid SCHEMBL9159882 | 0.68 | LMNA (0.71) | LMNAALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL1726999 | 0.68 | LMNA (0.71) | LMNAALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL29175486 | 0.67 | LMNA (0.59) | LMNACA1CA2CA7ALOX15 | |
| Acrylic Acid SCHEMBL28094417 | 0.66 | LMNA (0.67) | LMNAALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004444-A1 | Process for Producing Monomer for Fluorinated Resist | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004444-A1 | Process for Producing Monomer for Fluorinated Resist | ESD, AFF1, CAD | LMNA 2069/4885CA1 1447/4885CA2 2913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.